Biography: David Schellenberg is Director of the ACT Consortium (www.actconsortium.org), which works to answer key questions in malaria drug delivery, and co-Director of the Malaria Capacity Development Consortium (www.mcdconsortium.org), which is strengthening malaria research capacity in five African universities. David leads a DFID-funded programme to improve the use of data for decision making in 18 highly malaria burdened African countries and has worked on the clinical development of RTS,S with the Malaria Vaccine Initiative, GSK and research groups in 11 research centres in 7 African countries.
David's first degrees were in clinical science and medicine from the University of London, followed by a DTM&H from Liverpool, MRCP in London and a PhD in the University of Barcelona, Spain. He was based at the Ifakara Health Institute, Tanzania, between 1995-2001 and 2004-2007, working on a series of descriptive and intervention studies relating to child health, especially malaria. David chairs WHO's Surveillance, Monitoring and Evaluation Technical Expert Group for the Global Malaria Programme, has authored five annual reports for the UK's All Party Parliamentary Group on Malaria and NTD and was on the Task Force which developed Roll Back Malaria's 'AIM for a malaria free world' to guide global malaria control activities 2015-2030.Recordings will be made available later in the week via the GHLS Moodle page. Please also remember to leave your comments on the GHLS evaluation, also via the Moodle page.
Organisers: David Schellenberg and Heidi Larson
Administrator: Malcolm Chalmers
Admission
